Gattex, a New Medicine for Short Bowel Syndrome Has Been Approved by the FDA.

by Savitha C Muppala on  December 23, 2012 at 11:39 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Gattex (teduglutide) has received the approval by the U.S. Food and Drug Administration as a good form of treatment for nutritional problems caused by short bowel syndrome, which occurs after the small and/or large intestine is surgically removed.
 Gattex, a New Medicine for Short Bowel Syndrome Has Been Approved by the FDA.
Gattex, a New Medicine for Short Bowel Syndrome Has Been Approved by the FDA.

This injection is used to help improve intestinal absorption and is administered once a day. Somatropin and glutamine, two other drugs used to treat short bowel disorder have also been approved by the FDA.

Nausea, headache, abdominal pain and upper respiratory tract infection could be some of the common side effects. This drug was evaluated in two clinical studies and two extension studies.

This medicine provides nutrition for people whose intestines have been surgically removed since extensive removal of the intestines leads to poor absorption of liquids.

.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Crohns Disease Short Bowel Syndrome 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive